These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 6180284)

  • 21. Tumor response to interferon inducer and radiation effect of serum interferon levels.
    Lvovsky EA; D'Souza J; Eng D; D'Souza D; Lvovsky B; Hetland R; Craver WL; Sobel SH
    J Biol Regul Homeost Agents; 1988; 2(1):1-6. PubMed ID: 2459908
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Immune modulating effects of poly ICLC.
    Levy HB; Lvovsky E; Riley F; Harrington D; Anderson A; Moe J; Hilfenhaus J; Stephen E
    Ann N Y Acad Sci; 1980; 350():33-41. PubMed ID: 6972185
    [No Abstract]   [Full Text] [Related]  

  • 23. Preliminary trial of poly ICLC in chronic progressive multiple sclerosis.
    Bever CT; Salazar AM; Neely E; Ferraraccio BE; Rose JW; McFarland HF; Levy HB; McFarlin DE
    Neurology; 1986 Apr; 36(4):494-8. PubMed ID: 3960323
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Interferon induction by and toxicity of polyriboinosinic acid [poly(rI)].polyribocytidylic acid [poly (rC)], mismatched analog poly (rI).poly[r(C12Uracil)n], and poly(rI).poly(rC) L-lysine complexed with carboxymethylcellulose.
    Stringfellow DA; Weed SD
    Antimicrob Agents Chemother; 1980 Jun; 17(6):988-92. PubMed ID: 6157363
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evaluation of polyinosinic-polycytidylic and poly-L-lysine in metastatic breast cancer.
    Theriault RL; Hortobagyi GN; Buzdar AU; Levy HB; Hersh EM
    Cancer Treat Rep; 1986 Nov; 70(11):1341-2. PubMed ID: 3768878
    [No Abstract]   [Full Text] [Related]  

  • 26. An effective rabies treatment in exposed monkeys: a single dose of interferon inducer and vaccine.
    Baer GM; Moore SA; Shaddock JH; Levy HB
    Bull World Health Organ; 1979; 57(5):807-13. PubMed ID: 120234
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Biological characterization of MVE-2 and poly ICLC.
    Schlick E; Welker R; Piccoli M; Ruffmann R; Chirigos M
    Prog Clin Biol Res; 1984; 161():511-24. PubMed ID: 6483902
    [No Abstract]   [Full Text] [Related]  

  • 28. Vaccine adjuvant effects, and immune response, to synthetic polymers MVE and poly ICLC.
    Chirigos MA; Welker R; Schlick E; Saito T; Ruffmann R
    Prog Clin Biol Res; 1984; 161():467-79. PubMed ID: 6483899
    [No Abstract]   [Full Text] [Related]  

  • 29. The protective effect of polyriboinosinic acid-polyribocytidylic acid against the occurrence of galactosamine-induced liver cell injury in rat.
    Sakakibara S; Shibayama Y; Ueda I; Kagamiyama H
    Experientia; 1983 Feb; 39(2):174-6. PubMed ID: 6832294
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pharmacokinetics of interferon in blood, cerebrospinal fluid, and brain after administration of modified polyriboinosinic-polyribocytidylic acid and amphotericin B.
    Williams BB; Paul RT; Lerner AM
    J Infect Dis; 1982 Dec; 146(6):819-25. PubMed ID: 6183371
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Immune response modifying activity in mice of polyinosinic: polycytidylic acid stabilized with poly-L-lysine, in carboxymethylcellulose [poly-ICLC].
    Chirigos MA; Papademetriou V; Bartocci A; Read E; Levy HB
    Int J Immunopharmacol; 1981; 3(4):329-37. PubMed ID: 7333719
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Immunotherapeutic potential in murine tumor models of polyinosinic-polycytidylic acid and poly-L-lysine solubilized by carboxymethylcellulose.
    Talmadge JE; Adams J; Phillips H; Collins M; Lenz B; Schneider M; Chirigos M
    Cancer Res; 1985 Mar; 45(3):1066-72. PubMed ID: 3971361
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The effect of interferon induction in newborn piglets on the humoral immune response to oral vaccination with transmissible gastroenteritis virus.
    Derbyshire JB; Lesnick CE
    Vet Immunol Immunopathol; 1990 Mar; 24(3):227-34. PubMed ID: 1692649
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A preliminary trial of poly(I,C)-LC in multiple sclerosis.
    McFarlin DE; Bever CT; Salazar AM; Levy HB
    J Biol Response Mod; 1985 Oct; 4(5):544-8. PubMed ID: 2416885
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Phase I trials of poly(I,C) complexes in advanced cancer.
    Krown SE; Kerr D; Stewart WE; Field AK; Oettgen HF
    J Biol Response Mod; 1985 Dec; 4(6):640-9. PubMed ID: 2418162
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Stimulation of hematopoietic stem cells by interferon inducer in nonhuman primates receiving fractionated total body irradiation.
    Lvovsky EA; Levine PH; Bengali Z; Leiseca SA; Cicmanec JL; Robinson JE; Bautro N; Levy HB; Scott RM
    Int J Radiat Oncol Biol Phys; 1982 Oct; 8(10):1721-6. PubMed ID: 6759479
    [No Abstract]   [Full Text] [Related]  

  • 37. Enhanced therapeutic efficacy of poly(ICLC) and ribavirin combinations against Rift Valley fever virus infection in mice.
    Kende M; Lupton HW; Rill WL; Levy HB; Canonico PG
    Antimicrob Agents Chemother; 1987 Jul; 31(7):986-90. PubMed ID: 3662477
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Topical treatment of vaccinia virus infection with an interferon inducer in rabbits.
    Levy HB; Lvovsky E
    J Infect Dis; 1978 Jan; 137(1):78-81. PubMed ID: 624854
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Inhibition of virus-induced murine diabetes by an interferon inducer.
    Gadzik JP; Naji A; Barker CF; Blank KJ
    J Interferon Res; 1982; 2(1):59-63. PubMed ID: 6286804
    [No Abstract]   [Full Text] [Related]  

  • 40. [Treatment of autochthonous rat brain tumors with chemotherapy and radiotherapy].
    Nakamura O; Matsutani M; Nomura K; Shitara N; Takakura K; Ishizaki R
    Gan To Kagaku Ryoho; 1987 Apr; 14(4):1069-74. PubMed ID: 3032111
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.